The Central Nervous System department is involved in Blood Brain barrier passage experiments since 10 years now. CSF sampling and Microdialysis are 2 important tools used to evaluate the kinetics of Candidate Compounds but also their action on the Neurotransmitters.
We will present a poster entitled "In vivo Microdialysis a valuable tool for preclinical drug assesment" during the 7th Microdialysis Symposium in Poitiers, France, the 23rd and 24th of May 2013.
This poster will give you a...
Richard Mitry, CEO of Syncrosome, attended the Biochicago Congress last month in United-States.
It was a good opportunity to meet Biotech and Pharmaceutical companies from around the World.The one-to-one partnering meetings was really interessant to present our expertise in the field of In vivo preclinical evaluation and to get a real idea of the new candidate compounds currently in Research & Discovery phase.
Next congress in United-Sates will be organized so keep tuned to know where ...
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com